[1] 金庆跃,宋志燕,王丽华.围绝经期妇女疾病调查与健康质量评价[J].中国老年学杂志,2012,32(10):2137-2138.[2] Guidozzi F.Sleep and sleep disorders in menopausal women.Climacteric. 2013;16(2):214-219.[3] 胡雄峰.激素替代疗法在绝经期妇女骨质疏松中的效果观察[J].中国现代药物应用,2012,23(6):51-52.[4] Luger A, Mattsson AF, Koltowska-Häggström M, et al.Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study.Diabetes Care. 2012;35(1):57-62.[5] 胡雄峰.激素替代疗法在绝经期妇女骨质疏松中的效果观察[J].中国现代药物应用,2012,23(6):51-52.[6] 张向群,李红梅,尚敬红.舒坤汤治疗围绝经期综合征34例疗效观察[J].北京中医药大学学报,2009,32(5):354-355.[7] Lipov EG, Joshi JR, Sanders S,et al.A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD).Med Hypotheses. 2009;72(6):657-661.[8] Lipov EG, Slavin KV.More evidence supporting unified theory of stellate ganglion block.Med Hypotheses. 2013; 81(1):146.[9] Lipov EG, Joshi JR, Xie H, et al.Updated findings on the effects of stellate-ganglion block on hot flushes and night awakenings.Lancet Oncol. 2008;9(9):819-820. [10] 林菁,蒋萁.星状神经节阻滞结合针刺治疗女性更年期综合征的疗效观察[J]. 实用疼痛学杂志,2012,08(2):93-95.[11] van Gastel P, Kallewaard JW, van der Zanden M,et al. Stellate-ganglion block as a treatment for severe postmenopausal flushing.Climacteric. 2013;16(1):41-47.[12] 刘群会,朱祖欣.星状神经节阻滞治疗围绝经期失眠症26例疗效分析[J].中国综合临床,2012,23(12):7-9.[13] 王玲玲,张宝琴,张海泉,等.星状神经节阻滞治疗围绝经期综合征患者的激素水平变化及疗效分析[J].中国综合临床, 2009,25(6): 601-602.[14] 印武,周清华.星状神经节阻滞与应激反应[J].中华实用诊断与治疗杂志,2013,27(3):211-213.[15] 赵祉阳,樊宏.神经刺激仪引导腰骶丛阻滞治疗腰椎间盘突出症的临床研究[J].中国医药导报,2013,10(26):7-8. [16] 廖晖,李光辉,万里,等.连续腰丛联合坐骨神经阻滞对全膝关节置换术后疼痛及早期疗效的影响[J].中国疼痛医学杂志,2012, 18(10):614-617.[17] 陈敏,武庆平,姚尚龙.腰丛联合骶旁神经阻滞在交叉韧带重建术中的应用[J].临床麻醉学杂志,2014,30(1):39-42.[18] 周向群.家兔的发情与发情鉴定[J].代畜禽养殖业,1997,16(2): 17.[19] 刘辉.围绝经期综合征患者血清细胞因子IL-1β、IL-6、TNF-α的表达和临床意义[J].中国妇幼保健,2013,28(15):2462-2463.[20] Rosano GM, Fini M.Comparative cardiovascular effects of different progestins in menopause.Int J Fertil Womens Med. 2001; 46(5):248-256.[21] Prior JC.Progesterone or progestin as menopausal ovarian hormone therapy: recent physiology-based clinical evidence.Curr Opin Endocrinol Diabetes Obes. 2015;22(6): 495-501.[22] Valera MC, Gourdy P, Trémollières F, et al.From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition. Maturitas. 2015; 82(3):274-277.[23] 张敏,孙永,沈梅红,等.围绝经期综合征非药物疗法现状[J].中国老年学杂志,2014,34(24):7132-7134. |